Land: USA
Språk: engelska
Källa: NLM (National Library of Medicine)
ESZOPICLONE (UNII: UZX80K71OE) (ESZOPICLONE - UNII:UZX80K71OE)
DIRECT RX
ESZOPICLONE
ESZOPICLONE 1 mg
ORAL
PRESCRIPTION DRUG
Eszopiclone tablets are indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). Eszopiclone is contraindicated in patients with known hypersensitivity to eszopiclone. Hypersensitivity reactions include anaphylaxis and angioedema [see Warnings and Precautions (5.3)]. 8.1 Pregnancy Pregnancy Category C There are no adequate and well-controlled studies in pregnant women. Eszopiclone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Oral administration of eszopiclone to pregnant rats (62.5, 125, or 250 mg/kg/day) and
Eszopiclone tablets 1 mg are blue colored, circular, film-coated tablets, debossed with ‘S’ on one side and ‘1’ on other side. Bottles of 30’s with Child Resistant Cap……………..NDC 47335-586-83 Bottles of 100’s with Child Resistant Cap……………NDC 47335-586-88 Bottles of 100’s with Non Child Resistant Cap………NDC 47335-586-08 Bottles of 1000’s with Non Child Resistant Cap……..NDC 47335-586-18 Eszopiclone tablets 2 mg are white colored, circular, film-coated tablets, debossed with ‘S’ on one side and ‘2’ on other side. Bottles of 30’s with Child Resistant Cap……………..NDC 47335-587-83 Bottles of 100’s with Child Resistant Cap……………NDC 47335-587-88 Bottles of 100’s with Non Child Resistant Cap………NDC 47335-587-08 Bottles of 1000’s with Non Child Resistant Cap……..NDC 47335-587-18 Eszopiclone tablets 3 mg are dark blue colored, circular, film-coated tablets, debossed with ‘S’ on one side and ‘3’ on other side. Bottles of 30’s with Child Resistant Cap……………..NDC 47335-588-83 Bottles of 100’s with Child Resistant Cap……………NDC 47335-588-88 Bottles of 100’s with Non Child Resistant Cap………NDC 47335-588-08 Bottles of 1000’s with Non Child Resistant Cap……..NDC 47335-588-18 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in tight container with child-resistant closure.
Abbreviated New Drug Application
ESZOPICLONE- ESZOPICLONE TABLET, FILM COATED DIRECT RX ---------- SPL MEDGUIDE SECTION Eszopiclone Tablets, C-IV (ES-zoe-PIK-lone) Read the Medication Guide that comes with eszopiclone tablets before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your doctor about your medical condition or treatment. What is the most important information I should know about eszopiclone tablets? Do not take more eszopiclone tablets than prescribed. Do not take eszopiclone tablets unless you are able to stay in bed a full night (7 to 8 hours) before you must be active again. Take eszopiclone tablets right before you get in bed, not sooner. Eszopiclone tablets may cause serious side effects that you may not know are happening to you. These side effects include: sleepiness during the day not thinking clearly act strangely, confused, or upset “sleep-walking” or doing other activities when you are asleep like: eating talking having sex driving a car Call your healthcare provider right away if you find out that you have done any of the above activities after taking eszopiclone tablets. The morning after you take eszopiclone tablets your ability to drive safely and think clearly may be decreased. Do not take eszopiclone tablets if you: drank alcohol that evening or before bed take other medicines that can make you sleepy. Talk to your doctor about all of your medicines. Your doctor will tell you if you can take eszopiclone tablets with your other medicines cannot get a full night’s sleep WHAT ARE ESZOPICLONE TABLETS? Eszopiclone tablets aresedative-hypnotic (sleep) medicines.Eszopiclone tablets areused in adults for the treatment of a sleep problem called insomnia. Symptoms of insomnia include: trouble falling asleep waking up often during the night Eszopiclone tablets are not for children. Eszopiclone is a federally controlled substance (C-IV) because it can be abused or lead to dependence. Keep eszopiclone tablets in a safe place to pr Läs hela dokumentet
ESZOPICLONE- ESZOPICLONE TABLET, FILM COATED DIRECT RX ---------- ESZOPICLONE INDICATIONS & USAGE SECTION Eszopiclone tablets are indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). DOSAGE & ADMINISTRATION SECTION Use the lowest effective dose for the patient. 2.1 Dosage in Adults The recommended starting dose is 1 mg. Dosing can be raised to 2 mg or 3 mg if clinically indicated. In some patients, the higher morning blood levels of eszopiclone tablets following use of the 2 mg or 3 mg dose increase the risk of next day impairment of driving and other activities that require full alertness [see Warnings and Precautions (5.1)]. The total dose of eszopiclone tablets should not exceed 3 mg, once daily immediately before bedtime [see Warnings and Precautions (5.6)]. 2.2 Geriatric or Debilitated Patients The total dose of eszopiclone tablets should not exceed 2 mg in elderly or debilitated patients. 2.3 Patients with Severe Hepatic Impairment, or Taking Potent CYP3A4 Inhibitors In patients with severe hepatic impairment, or in patients coadministered eszopiclone tablets with potent CYP3A4 inhibitors, the total dose of eszopiclone tablets should not exceed 2 mg [see Warning and Precautions (5.7)]. 2.4 Use with CNS Depressants Dosage adjustments may be necessary when eszopiclone tablets is combined with other CNS depressant drugs because of the potentially additive effects [see Warnings and Precautions (5.1)]. 2.5 Administration with Food Taking eszopiclone tablets with or immediately after a heavy, high-fat meal results in slower absorption and would be expected to reduce the Läs hela dokumentet